" class="no-js "lang="en-US"> Sophie Papa - Medtech Alert
Saturday, September 13, 2025
Sophie Papa

Sophie Papa

About Sophie Papa

Dr. Papa is chief medical officer at Enara Bio. Previously, she was a consultant medical oncologist at King’s College London (KCL) and Guy’s and St Thomas’ NHS Foundation Trust (GSTFT), where she remains a clinical reader in immuno-oncology. Sophie has extensive clinical trial experience as a principal investigator in the GSTFT early phase trials team, with a particular focus on the design and delivery of first-in-human studies of T-cell therapies for solid tumours. Sophie completed her medical training at the University of Oxford and Imperial College London, and went on to complete a PhD in solid tumour CAR T-cell cancer immunotherapy at King’s College London.

Related Story

RemedyBio Introduces Scientific Advisory Board

May 26 2022

RemedyBio, a biotech company pioneering its proprietary ultra-high throughput single cell Nanoreactor™ platform for discovery […]